Andrews R. Robbins's Insider Trades & SAST Disclosures

Andrews R. Robbins's most recent trade in Cogent Biosciences Inc was a trade of 915,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.

Share

Note

This is a custom search result for pattern Andrews R. Robbins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	915,000	915,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	1,100,000	1,100,000	-		-	Stock Option (Right to Buy)
Harpoon Therapeutics Inc	Andrews R. Robbins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jun 2023	23,000	23,000	-		-	Director Stock Option (Right to Buy)
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2023	525,000	525,000	-		-	Stock Option (Right to Buy)
Harpoon Therapeutics Inc	Andrews R. Robbins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jun 2022	10,167	10,167	-		-	Director Stock Option (Right to Buy)
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2022	690,000	690,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2021	315,200	315,200	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Oct 2020	7,442,421	7,442,421	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades